Activation of the mTOR pathway by the amino acid l-leucine in the 5q- syndrome and other ribosomopathies

Advances in Biological Regulation

Volumn 53, Issue 1, 2013, Pages 8-17

  Boultwood, Jacqueline ^a   Yip, Bon Ham ^a   Vuppusetty, Chaitanya ^a   Pellagatti, Andrea ^a   Wainscoat, James S ^a  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84874010025     PISSN: 22124926     EISSN: None     Source Type: Book Series    
DOI: 10.1016/j.jbior.2012.09.002     Document Type: Review

References (65)

1. Anthony J.C., Yoshizawa F., Anthony T.G., Vary T.C., Jefferson L.S., Kimball S.R. Leucine stimulates translation initiation in skeletal muscle of postabsorptive rats via a rapamycin-sensitive pathway. J Nutr 2000, 130:2413-2419.
2. Avruch J., Long X., Ortiz-Vega S., Rapley J., Papageorgiou A., Dai N. Amino acid regulation of TOR complex 1. Am J Physiol Endocrinol Metab 2009, 296:E592-E602.
3. Bhaskar P.T., Hay N. The two TORCs and Akt. Dev Cell 2007, 12:487-502.
4. Boultwood J., Pellagatti A., McKenzie A.N., Wainscoat J.S. Advances in the 5q- syndrome. Blood 2010, 116:5803-5811.
5. Boultwood J., Pellagatti A., Wainscoat J.S. Haploinsufficiency of ribosomal proteins and p53 activation in anemia: Diamond-Blackfan anemia and the 5q- syndrome. Adv Biol Regul 2012, 52:196-203.
6. Brown E.J., Albers M.W., Shin T.B., Ichikawa K., Keith C.T., Lane W.S., et al. A mammalian protein targeted by G1-arresting rapamycin-receptor complex. Nature 1994, 369:756-758.
7. Cmejlova J., Dolezalova L., Pospisilova D., Petrtylova K., Petrak J., Cmejla R. Translational efficiency in patients with Diamond-Blackfan anemia. Haematologica 2006, 91:1456-1464.
8. Cohen A., Hall M.N. An amino acid shuffle activates mTORC1. Cell 2009, 136:399-400.
9. Crozier S.J., Kimball S.R., Emmert S.W., Anthony J.C., Jefferson L.S. Oral leucine administration stimulates protein synthesis in rat skeletal muscle. J Nutr 2005, 135:376-382.
10. Dodd K.M., Tee A.R. Leucine and mTORC1: a complex relationship. Am J Physiol Endocrinol Metab 2012, 302:E1329-E1342.
11. Drakos E., Atsaves V., Li J., Leventaki V., Andreeff M., Medeiros L.J., et al. Stabilization and activation of p53 downregulates mTOR signaling through AMPK in mantle cell lymphoma. Leukemia 2009, 23:784-790.
12. Dutt S., Narla A., Lin K., Mullally A., Abayasekara N., Megerdichian C., et al. Haploinsufficiency for ribosomal protein genes causes selective activation of p53 in human erythroid progenitor cells. Blood 2011, 117:2567-2576.
13. Ebert B.L., Pretz J., Bosco J., Chang C.Y., Tamayo P., Galili N., et al. Identification of RPS14 as a 5q- syndrome gene by RNA interference screen. Nature 2008, 451:335-339.
14. Engelman J.A., Luo J., Cantley L.C. The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism. Nat Rev Genet 2006, 7:606-619.
15. Faivre S., Kroemer G., Raymond E. Current development of mTOR inhibitors as anticancer agents. Nat Rev Drug Discov 2006, 5:671-688.
16. Feng Z., Zhang H., Levine A.J., Jin S. The coordinate regulation of the p53 and mTOR pathways in cells. Proc Natl Acad Sci U S A 2005, 102:8204-8209.
17. Foster K.G., Fingar D.C. Mammalian target of rapamycin (mTOR): conducting the cellular signaling symphony. J Biol Chem 2010, 285:14071-14077.
18. Fuchs B.C., Bode B.P. Amino acid transporters ASCT2 and LAT1 in cancer: partners in crime?. Semin Cancer Biol 2005, 15:254-266.
19. Gazda H.T., Kho A.T., Sanoudou D., Zaucha J.M., Kohane I.S., Sieff C.A., et al. Defective ribosomal protein gene expression alters transcription, translation, apoptosis, and oncogenic pathways in Diamond-Blackfan anemia. Stem Cells 2006, 24:2034-2044.
20. Han J.M., Jeong S.J., Park M.C., Kim G., Kwon N.H., Kim H.K., et al. Leucyl-tRNA synthetase is an intracellular leucine sensor for the mTORC1-signaling pathway. Cell 2012, 149:410-424.
21. Hara K., Yonezawa K., Weng Q.P., Kozlowski M.T., Belham C., Avruch J. Amino acid sufficiency and mTOR regulate p70 S6 kinase and eIF-4E BP1 through a common effector mechanism. J Biol Chem 1998, 273:14484-14494.
22. Hay N., Sonenberg N. Upstream and downstream of mTOR. Genes Dev 2004, 18:1926-1945.
23. Heitman J., Movva N.R., Hall M.N. Targets for cell cycle arrest by the immunosuppressant rapamycin in yeast. Science 1991, 253:905-909.
24. Holz M.K., Ballif B.A., Gygi S.P., Blenis J. mTOR and S6K1 mediate assembly of the translation preinitiation complex through dynamic protein interchange and ordered phosphorylation events. Cell 2005, 123:569-580.
25. Horton L.E., Bushell M., Barth-Baus D., Tilleray V.J., Clemens M.J., Hensold J.O. p53 activation results in rapid dephosphorylation of the eIF4E-binding protein 4E-BP1, inhibition of ribosomal protein S6 kinase and inhibition of translation initiation. Oncogene 2002, 21:5325-5334.
26. Jaako P., Debnath S., Olsson K., Bryder D., Flygare J., Karlsson S. Dietary L-leucine improves the anemia in a mouse model for Diamond-Blackfan anemia. Blood 2012, 120:2225-2228.
27. Jastrzebski K., Hannan K.M., Tchoubrieva E.B., Hannan R.D., Pearson R.B. Coordinate regulation of ribosome biogenesis and function by the ribosomal protein S6 kinase, a key mediator of mTOR function. Growth Factors 2007, 25:209-226.
28. Jefferies H.B., Fumagalli S., Dennis P.B., Reinhard C., Pearson R.B., Thomas G. Rapamycin suppresses 5'TOP mRNA translation through inhibition of p70s6k. EMBO J 1997, 16:3693-3704.
29. Kean K.M. The role of mRNA 5'-noncoding and 3'-end sequences on 40S ribosomal subunit recruitment, and how RNA viruses successfully compete with cellular mRNAs to ensure their own protein synthesis. Biol Cell 2003, 95:129-139.
30. Kim E., Goraksha-Hicks P., Li L., Neufeld T.P., Guan K.L. Regulation of TORC1 by Rag GTPases in nutrient response. Nat Cell Biol 2008, 10:935-945.
31. Lim H.K., Choi Y.A., Park W., Lee T., Ryu S.H., Kim S.Y., et al. Phosphatidic acid regulates systemic inflammatory responses by modulating the Akt-mammalian target of rapamycin-p70 S6 kinase 1 pathway. J Biol Chem 2003, 278:45117-45127.
32. Ma X.M., Blenis J. Molecular mechanisms of mTOR-mediated translational control. Nat Rev Mol Cell Biol 2009, 10:307-318.
33. Ma X.M., Yoon S.O., Richardson C.J., Julich K., Blenis J. SKAR links pre-mRNA splicing to mTOR/S6K1-mediated enhanced translation efficiency of spliced mRNAs. Cell 2008, 133:303-313.
34. Magnuson B., Ekim B., Fingar D.C. Regulation and function of ribosomal protein S6 kinase (S6K) within mTOR signalling networks. Biochem J 2012, 441:1-21.
35. Meyuhas O. Synthesis of the translational apparatus is regulated at the translational level. Eur J Biochem 2000, 267:6321-6330.
36. Meyuhas O., Dreazen A. Ribosomal protein S6 kinase from TOP mRNAs to cell size. Prog Mol Biol Transl Sci 2009, 90:109-153.
37. Narla A., Ebert B.L. Ribosomopathies: human disorders of ribosome dysfunction. Blood 2010, 115:3196-3205.
38. Narla A., Ebert B.L. Translational medicine: ribosomopathies. Blood 2011, 118:4300-4301.
39. Nicklin P., Bergman P., Zhang B., Triantafellow E., Wang H., Nyfeler B., et al. Bidirectional transport of amino acids regulates mTOR and autophagy. Cell 2009, 136:521-534.
40. Pause A., Belsham G.J., Gingras A.C., Donze O., Lin T.A., Lawrence J.C., et al. Insulin-dependent stimulation of protein synthesis by phosphorylation of a regulator of 5'-cap function. Nature 1994, 371:762-767.
41. Payne E., Virgilio M., Narla A., Sun H., Levine M., Paw B.H., et al. L-Leucine improves anemia and developmental defects associated with Diamond-Blackfan anemia and del(5q)MDS by activating the mTOR pathway. Blood 2012, 120:2214-2224.
42. Pellagatti A., Hellstrom-Lindberg E., Giagounidis A., Perry J., Malcovati L., Della Porta M.G., et al. Haploinsufficiency of RPS14 in 5q- syndrome is associated with deregulation of ribosomal- and translation-related genes. Br J Haematol 2008, 142:57-64.
43. Populo H., Lopes J.M., Soares P. The mTOR signalling pathway in human cancer. Int J Mol Sci 2012, 13:1886-1918.
44. Pospisilova D., Cmejlova J., Hak J., Adam T., Cmejla R. Successful treatment of a Diamond-Blackfan anemia patient with amino acid leucine. Haematologica 2007, 92:e66-e67.
45. Pyronnet S., Imataka H., Gingras A.C., Fukunaga R., Hunter T., Sonenberg N. Human eukaryotic translation initiation factor 4G (eIF4G) recruits mnk1 to phosphorylate eIF4E. EMBO J 1999, 18:270-279.
46. Riley T., Sontag E., Chen P., Levine A. Transcriptional control of human p53-regulated genes. Nat Rev Mol Cell Biol 2008, 9:402-412.
47. Roccio M., Bos J.L., Zwartkruis F.J. Regulation of the small GTPase Rheb by amino acids. Oncogene 2006, 25:657-664.
48. Sabers C.J., Martin M.M., Brunn G.J., Williams J.M., Dumont F.J., Wiederrecht G., et al. Isolation of a protein target of the FKBP12-rapamycin complex in mammalian cells. J Biol Chem 1995, 270:815-822.
49. Sancak Y., Bar-Peled L., Zoncu R., Markhard A.L., Nada S., Sabatini D.M. Ragulator-Rag complex targets mTORC1 to the lysosomal surface and is necessary for its activation by amino acids. Cell 2010, 141:290-303.
50. Sancak Y., Peterson T.R., Shaul Y.D., Lindquist R.A., Thoreen C.C., Bar-Peled L., et al. The Rag GTPases bind raptor and mediate amino acid signaling to mTORC1. Science 2008, 320:1496-1501.
51. Schalm S.S., Blenis J. Identification of a conserved motif required for mTOR signaling. Curr Biol 2002, 12:632-639.
52. Schalm S.S., Fingar D.C., Sabatini D.M., Blenis J. TOS motif-mediated raptor binding regulates 4E-BP1 multisite phosphorylation and function. Curr Biol 2003, 13:797-806.
53. Segev N., Hay N. Hijacking leucyl-tRNA synthetase for amino acid-dependent regulation of TORC1. Mol Cell 2012, 46:4-6.
54. Sen S., Wang H., Nghiem C.L., Zhou K., Yau J., Tailor C.S., et al. The ribosome-related protein, SBDS, is critical for normal erythropoiesis. Blood 2011, 118:6407-6417.
55. Smith E.M., Finn S.G., Tee A.R., Browne G.J., Proud C.G. The tuberous sclerosis protein TSC2 is not required for the regulation of the mammalian target of rapamycin by amino acids and certain cellular stresses. J Biol Chem 2005, 280:18717-18727.
56. Sonenberg N., Gingras A.C. The mRNA 5' cap-binding protein eIF4E and control of cell growth. Curr Opin Cell Biol 1998, 10:268-275.
57. Stipanuk M.H. Leucine and protein synthesis: mTOR and beyond. Nutr Rev 2007, 65:122-129.
58. Tang H., Hornstein E., Stolovich M., Levy G., Livingstone M., Templeton D., et al. Amino acid-induced translation of TOP mRNAs is fully dependent on phosphatidylinositol 3-kinase-mediated signaling, is partially inhibited by rapamycin, and is independent of S6K1 and rpS6 phosphorylation. Mol Cell Biol 2001, 21:8671-8683.
59. Tee A.R., Manning B.D., Roux P.P., Cantley L.C., Blenis J. Tuberous sclerosis complex gene products, Tuberin and Hamartin, control mTOR signaling by acting as a GTPase-activating protein complex toward Rheb. Curr Biol 2003, 13:1259-1268.
60. Thoreen C.C., Chantranupong L., Keys H.R., Wang T., Gray N.S., Sabatini D.M. A unifying model for mTORC1-mediated regulation of mRNA translation. Nature 2012, 485:109-113.
61. Vander Haar E., Lee S.I., Bandhakavi S., Griffin T.J., Kim D.H. Insulin signalling to mTOR mediated by the Akt/PKB substrate PRAS40. Nat Cell Biol 2007, 9:316-323.
62. Wang X., Li W., Williams M., Terada N., Alessi D.R., Proud C.G. Regulation of elongation factor 2 kinase by p90(RSK1) and p70 S6 kinase. EMBO J 2001, 20:4370-4379.
63. Wilson K.F., Wu W.J., Cerione R.A. Cdc42 stimulates RNA splicing via the S6 kinase and a novel S6 kinase target, the nuclear cap-binding complex. J Biol Chem 2000, 275:37307-37310.
64. Yip B.H., Pellagatti A., Vuppusetty C., Giagounidis A., Germing U., Lamikanra A.A., et al. Effects of L-leucine in 5q- syndrome and other RPS14-deficient erythroblasts. Leukemia 2012, 26:2154-2158.
65. Zoncu R., Efeyan A., Sabatini D.M. mTOR: from growth signal integration to cancer, diabetes and ageing. Nat Rev Mol Cell Biol 2011, 12:21-35.